FCN3 and hepatocellular carcinoma: We demonstrate that FCN3 overexpression efficiently sensitizes HCC cells to ferroptosis by downregulating MUFA levels, leading to the inhibition of the oncogenesis and progression of both primary hepatocellular carcinoma and subcutaneous HCC xenograft.